AT&T Stock Price Prediction: Bull and Bear Case

AT&T (NYSE:T | T Price Prediction) has been one of the steadier performers in the Communication Services sector in 2026. The 24/7 Wall St. price target for AT&T is $30.34, representing approximately 14.43% upside from the current price of $26.51. Our rating is buy, with a high confidence level of 90%.

The 24/7 Wall St. price target aligns with Wall Street consensus of $30.39. The high-confidence reading reflects consistent earnings execution, improving cash flow guidance, and a compelling dividend yield relative to peers.

Fiber Growth Drives Momentum

AT&T gained 9.1% year-to-date through April 17, 2026. The stock trades between its 52-week low of $22.71 and 52-week high of $29.14, currently near the upper half of that range.

In Q4 2025, AT&T posted adjusted EPS of $0.52 against consensus of $0.46, exceeding expectations by 10.64%. Revenue of $33.47B exceeded estimates by 1.92% and grew 3.6% year over year. The earnings beat drove a 13.09% one-week stock gain, significantly outperforming the S&P 500, which fell 1.3% over the same 30-day window.

Bull Case: $31+ as Fiber and Free Cash Flow Accelerate

The bull case rests on three pillars. First, fiber expansion continues delivering. AT&T ended 2025 with 10.4 million fiber connections, up 11.5% year over year, and added 283,000 net fiber subscribers in Q4 alone. Management noted this was the best consumer broadband subscriber growth in a decade. With 32 million consumer and business locations already passed, the addressable base remains large.

Second, free cash flow is accelerating. Guidance calls for $18B+ in free cash flow in 2026, rising to $19B+ in 2027 and $21B+ in 2028. This supports both the $1.11 annualized dividend and the $8B in share repurchases planned for 2026 under a new $10B buyback authorization.

Third, tax savings from the One Big Beautiful Bill Act are expected to deliver $1.0 to $1.5B in annual cash tax relief, with $3.5B earmarked to accelerate fiber deployment.

Our bull scenario reaches $31.67 by April 2027. Wells Fargo maintains an Overweight rating with a $28 price target (raised from $27). Analyst consensus sits at with 4 Strong Buy and 12 Buy ratings out of 25 analysts bullish.

Bear Case: Debt, Competition, and Legacy Drag

The bear case centers on leverage, competitive pressure, and legacy wireline decline. The Lumen Mass Markets and EchoStar spectrum acquisitions push net debt/EBITDA to approximately 3.2x, with both deals expected to be dilutive to EPS in 2026 and 2027.

Business Wireline revenue fell 7.5% year over year in Q4, with legacy down 17.5%. The legacy segment will generate negative EBITDA after 2027 until copper decommissioning is complete. Short interest has risen 20.5% to 118.25 million shares.

T-Mobile continues pressing its 5G coverage advantage and has expanded into AI-native network infrastructure, which could pressure AT&T’s subscriber growth.

AT&T’s trailing P/E of 9x is well below sector averages. The free cash flow ramp through 2028 provides a credible deleveraging path to 2.5x net debt/EBITDA target. The bear scenario still produces a $27.37 price by April 2027, suggesting limited downside.

AT&T Price Projections: 2026 to 2030

These projections assume AT&T executes on fiber expansion and free cash flow commitments. Upside could emerge if Lumen integration delivers ahead of schedule or copper decommissioning accelerates. Downside risk ties to competitive pressure from T-Mobile and Verizon’s fiber buildout via Frontier.

A Steady Compounder With a Credible Path Higher

The 24/7 Wall St. price target of $30.34 carries a high-confidence buy rating. AT&T is not a high-growth story, but does not need to be. The combination of a 4.2% dividend yield, a credible free cash flow ramp to $21B+ by 2028, and a trailing P/E of 9x gives the risk/reward profile a favorable skew based on current fundamentals.

Key risks to monitor include leverage remaining above 3x into 2027 or fiber net adds stalling below the 1 million annual threshold AT&T has achieved for eight consecutive years.

At $26.51, the combination of dividend income and a credible capital appreciation path gives the risk/reward profile a favorable skew for patient investors.